Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, 26 September 2015, Vol 295, No 7881

Sort by: Newest first Oldest first A-Z Z-A

  • Victims of Creutzfeldt–Jakob disease (CJD) show evidence of Alzheimer’s pathology, suggests new research. In the image, micrograph of a brain with CJD

    Brains of CJD victims show signs of Alzheimer’s pathology Subscription

    15 SEP 2015 15:50 By Ingrid Torjesen
    Comments (1)

    Victims of Creutzfeldt–Jakob disease show evidence of Alzheimer’s pathology, suggests new research. But neuroscientists have quashed fears that people can “catch” Alzheimer’s.

  • Making a mistake at work can leave anyone lacking confidence and unsure how to proceed. This article discusses how pharmacists should deal with errors and overcome the aftermath. In the image, a person walks towards the light at the end of a tunnel

    How to recover from making a mistake at work Subscription

    15 SEP 2015 14:32 By Ross Ferguson
    Comments (2)

    Making a mistake at work can leave anyone lacking confidence and unsure how to proceed. So how should pharmacists deal with errors and overcome the aftermath?

  • Exam failures help control pharmacist numbers Subscription

    15 SEP 2015 10:39 By Barry Shooter

    The news story on research that correlated lower entry standards and registration assessment failure rates (The Pharmaceutical Journal

  • Use of tranexamic acid is inexpensive and has shown efficacy in reducing perioperative blood loss and the need for transfusions. In the image, a person has a blood transfusion

    Tranexamic acid can cut the need for blood transfusions after surgery Subscription

    15 SEP 2015 10:13 By Debbie Andalo, Janna Lawrence

    A hospital reduced the need for red blood cell transfusions by 40% for patients undergoing a full knee or hip replacement when they routinely gave them tranexamic acid, according to new research.

  • All pharmacists employed by health boards and trusts in Wales should engage with the Royal Pharmaceutical Society Faculty processes, according to the All Wales Chief Pharmacist Committee.

    Welsh chief pharmacists say NHS pharmacists should 'engage with' RPS Faculty Subscription

    14 SEP 2015 17:11

    All pharmacists employed by health boards and trusts in Wales should engage with the Royal Pharmaceutical Society Faculty processes, according to the All Wales Chief Pharmacist Committee.

  • Extensive training would equip pharmacists with the right skills Subscription

    14 SEP 2015 14:11 By Richard O' Connell
    Comments (1)

    Regarding pharmacist training for clinical roles, perhaps it would be a good idea to follow a similar approach to that of medical students and junior doctors. This would include multiple long practice placements during the university years, which now appears to have unanimous support. Then, once qualified, junior pharmacists would rotate through all the different specialist areas in hospital and community. This would allow them to gain an understanding of clinical approaches and specialist ...

  • rps-conference-awards

    2015 RPS award winners announced Subscription

    13 SEP 2015 23:18 By Harriet Adcock

    The winners of this year’s Royal Pharmaceutical Society Awards were revealed at the annual conference in Birmingham on 13 September 2015.

  • September 2015: SMC decisions Subscription

    11 SEP 2015 11:12

    The Scottish Medicines Consortium (SMC) has accepted the following medicines for NHS Scotland for particular indications: aflibercept (Eylea; Bayer); bortezomib (Velcade; Janssen-Cilag); ledipasvir/sofosbuvir (Harvoni; Gilead); lisdexamfetamine (Elvanse; Shire); pasireotide (Signifor; Novartis); sitagliptin (Januvia; Merck Sharp & Dohme). Bevacizumab (Avastin; Roche) has been accepted for restricted use in combination with pacitaxel ...

  • Drug safety alert for proton pump inhibitors Subscription

    11 SEP 2015 11:06

    The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update relating to proton pump inhibitors (PPIs). The update states that PPIs are associated very infrequently with cases of subacute cutaneous lupus erythematosus (SCLE), a non-scarring dermatosis that can develop in sun-exposed areas.

  • EPS workshops for community pharmacies Subscription

    11 SEP 2015 10:58

    The Health and Social Care Information Centre (HSCIC) is running training events about the electronic prescription service (EPS) for all staff working in community pharmacy and for dispensing appliance contractors in England. There will be at least seven training sessions in each local pharmaceutical committee (LPC) area, covering each of the patient medication record (PMR) systems: Analyst; CoMPaSS; NexPhase; Pharmacy Manager; ProScript; ProScript LINK; Rx Webb. The Pharmaceutical ...

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.